LIVE @ESC22: Cardio-Oncology Guidelines: Key Messages & Question Time

Dr Alexander Lyon is a leading London-based consultant cardiologist, specialising in the field of heart failure, cardiomyopathy, cardio-oncology and takotsubo syndrome. He is highly experienced, and is well-versed in all aspects of cardiology. Along with his private clinics at Royal Brompton Hospital and in central London, he is also senior lecturer for the National Heart and Lung Institute at Imperial College London.

Dr Lyon graduated with a first class degree from Oxford University, and gained experience doing post-graduate training in London and Sydney before setting up private practice in London. His clinical interests are in the field of heart failure, chemotherapy cardiomyopathy and Takotsubo cardiomyopathy, and he is the theme leader for heart failure research in the NIHR-funded Biomedical Research Unit at the Royal Brompton Hospital.

Prof Teresa López Fernández is a clinical investigator and consultant cardiologist at La Paz University Hospital in Madrid, ES. She specialises in cardiac imaging (she is board certified in advanced and transesophageal echocardiography by the European Society of Cardiology (ESC)) and cardio-oncology (she is board certified by the International Cardio-Oncology Society), and currently coordinates the cardio-oncology team at La Paz University Hospital. She is the founder and chair of the Spanish Cardio-Oncology Working Group at the Spanish Society of Cardiology (SEC) and the Secretary of the ESC Council of Cardio-Oncology.

Dr Arjun Ghosh MBBS, MRCP (UK), MRCP (Card), MSc, PhD, FHEA, FACC, is a Consultant Cardiologist at Barts Heart Centre (BHC), St. Bartholomew’s Hospital, London and at University College London Hospital (UCLH).

He is the first Cardiologist in the UK to be appointed specifically in Cardio-Oncology and helped establish Cardio-Oncology services at both these hospitals. The services deal with screening for cardiotoxicity, monitoring patients on potentially cardiotoxic therapy and managing cardiac complications of cancer therapy. Alongside the clinical service, Cardio-Oncology research is undertaken at both sites and there is a thriving educational component to the service with fellows from the UK and across the world.

Arjun is also actively involved in developing Cardio-Oncology guidelines and changing practice through the British Society of Echocardiography, British Cardio-Oncology Society and International Cardio-Oncology Society. He also runs the UK’s only national Cardio-Oncology Study Day and is organizing the first European Cardio-oncology Symposium which will be held in Barcelona in October 2019.